O2-8-5Prognostic Value of Subtype Changes After Neoadjuvant Chemotherapy in Primary Breast Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Neoadjuvant Chemotherapy in Breast Cancer

English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

Impact of Molecular Subtype Conversion of Breast Cancers After Neoadjuvant Chemotherapy on Clinical Outcome

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Towards De-Escalation of Axillary Management After Neoadjuvant Chemotherapy in Breast Cancer

English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Changes in Cytokeratin 18 During Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study

Iranian Journal of Pathology
Forensic MedicinePathology
2020English

Associations of Lymphovascular Invasion and Clinical Outcomes in Breast Cancer After Neoadjuvant Chemotherapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Evaluation of Ki-67 Proliferation and Apoptotic Index Before, During and After Neoadjuvant Chemotherapy for Primary Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy